---
title: "MedTech Cybersecurity: 8 Moves for Global Submissions"
description: "Eight concrete moves that turn medical-device cybersecurity from a market-entry tax into a global accelerant. SPDF, SBOM, threat modeling, CVD, post-market."
lang: en
json-ld: |
  [
    {
      "@context": "https://schema.org",
      "@type": "WebSite",
      "name": "The Medical Device Cybersecurity Crosswalk",
      "alternateName": "MDC Crosswalk",
      "url": "https://mdccrosswalk.com/",
      "description": "Compare FDA, EU MDR, MHRA, PMDA, NMPA, TGA, MFDS and Health Canada medical device cybersecurity requirements across 29 jurisdictions."
    },
    {
      "@context": "https://schema.org",
      "@type": "Organization",
      "name": "MDC Crosswalk",
      "url": "https://mdccrosswalk.com/",
      "logo": "https://mdccrosswalk.com/favicon.png",
      "sameAs": [
        "https://bluegoatcyber.com"
      ],
      "description": "An editorial reference comparing global medical-device cybersecurity regulations. Maintained by Blue Goat Cyber."
    },
    {
      "@context": "https://schema.org",
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://mdccrosswalk.lovable.app/"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Playbook",
          "item": "https://mdccrosswalk.lovable.app/playbook"
        }
      ]
    },
    {
      "@context": "https://schema.org",
      "@type": "HowTo",
      "name": "Eight moves for global MedTech cybersecurity submissions",
      "step": [
        {
          "@type": "HowToStep",
          "position": 1,
          "name": "Map your target markets",
          "text": "Stack-rank jurisdictions by revenue potential, time-to-clearance and reciprocity (MDSAP, MRA, reference jurisdiction routes). Most US-cleared devices reach Canada and Singapore 60–90% faster via abridged routes."
        },
        {
          "@type": "HowToStep",
          "position": 2,
          "name": "Build to the highest baseline",
          "text": "Design once against IEC 81001-5-1 + IEC 62443-4-1 + AAMI TIR57 inside your ISO 13485 / QMSR design controls. The FDA (Feb 2026 guidance now anchored on QMSR), PMDA, EU and HSA all converge here - treat SPDF as one satisfaction path within the QMS, not a parallel document set."
        },
        {
          "@type": "HowToStep",
          "position": 3,
          "name": "Generate one SBOM, format it three ways",
          "text": "SPDX 2.3 for the FDA, CycloneDX for industry partners, and a human-readable PDF for Notified Bodies and PMDA reviewers."
        },
        {
          "@type": "HowToStep",
          "position": 4,
          "name": "Stand up a CVD program before submission",
          "text": "FDA, PMDA and Health Canada expect a coordinated vulnerability disclosure plan in the submission itself, not as a post-clearance promise."
        },
        {
          "@type": "HowToStep",
          "position": 5,
          "name": "Localise post-market obligations",
          "text": "Cyber-incident clocks are tight and uneven: China 24h, EU CRA 24h early-warning + 72h full notification (from 11 Sep 2026), US FDA 30 days. Build one playbook with regional triggers and language packs - and design to the 24h floor, not the 15-day MDR vigilance clock."
        },
        {
          "@type": "HowToStep",
          "position": 6,
          "name": "Plan for divergence, not convergence",
          "text": "CRA (EU, 2027), AI Act, China MLPS evolution will pull standards apart again. Architect for configurability, crypto agility, regional telemetry, kill-switches."
        },
        {
          "@type": "HowToStep",
          "position": 7,
          "name": "Get an external pen test before submission",
          "text": "FDA reviewers increasingly expect third-party security testing evidence. SFDA and HSA reviewers reuse it. One report, many submissions."
        },
        {
          "@type": "HowToStep",
          "position": 8,
          "name": "Treat MDSAP as your QMS keystone",
          "text": "MDSAP audit covers AU, BR, CA, JP, US in one go, and MDSAP-aligned ISO 13485 evidence now maps 1:1 to the FDA QMSR that took effect Feb 2 2026. Embed cybersecurity QMS controls (design controls, CAPA, complaint handling) so they pass MDSAP + QMSR review without rework."
        }
      ]
    }
  ]
---

[

The Crosswalk



](/)

[Overview](/)[Playbook](/playbook)CompareReference

[New Per-page social previews and this changelog ](/changelog "Per-page social previews and this changelog") Search⌘K

1.  [Home ](/)
2.  Playbook 

The playbook

# Eight moves that turn cybersecurity into a global accelerant.

What we wish every MedTech founder knew before their first international submission.

Last updated · July 25, 2026 

Share Copy link X LinkedIn Email

## The eight moves

1.  01 
    
    ### Map your target markets
    
    Stack-rank jurisdictions by revenue potential, time-to-clearance and reciprocity (MDSAP, MRA, reference jurisdiction routes). Most US-cleared devices reach Canada and Singapore 60–90% faster via abridged routes.
    
2.  02 
    
    ### Build to the highest baseline
    
    Design once against IEC 81001-5-1 + IEC 62443-4-1 + AAMI TIR57 inside your ISO 13485 / QMSR design controls. The FDA (Feb 2026 guidance now anchored on QMSR), PMDA, EU and HSA all converge here - treat SPDF as one satisfaction path within the QMS, not a parallel document set.
    
3.  03 
    
    ### Generate one SBOM, format it three ways
    
    SPDX 2.3 for the FDA, CycloneDX for industry partners, and a human-readable PDF for Notified Bodies and PMDA reviewers.
    
4.  04 
    
    ### Stand up a CVD program before submission
    
    FDA, PMDA and Health Canada expect a coordinated vulnerability disclosure plan in the submission itself, not as a post-clearance promise.
    
5.  05 
    
    ### Localise post-market obligations
    
    Cyber-incident clocks are tight and uneven: China 24h, EU CRA 24h early-warning + 72h full notification (from 11 Sep 2026), US FDA 30 days. Build one playbook with regional triggers and language packs - and design to the 24h floor, not the 15-day MDR vigilance clock.
    
6.  06 
    
    ### Plan for divergence, not convergence
    
    CRA (EU, 2027), AI Act, China MLPS evolution will pull standards apart again. Architect for configurability, crypto agility, regional telemetry, kill-switches.
    
7.  07 
    
    ### Get an external pen test before submission
    
    FDA reviewers increasingly expect third-party security testing evidence. SFDA and HSA reviewers reuse it. One report, many submissions.
    
8.  08 
    
    ### Treat MDSAP as your QMS keystone
    
    MDSAP audit covers AU, BR, CA, JP, US in one go, and MDSAP-aligned ISO 13485 evidence now maps 1:1 to the FDA QMSR that took effect Feb 2 2026. Embed cybersecurity QMS controls (design controls, CAPA, complaint handling) so they pass MDSAP + QMSR review without rework.
    

Sponsored note · Blue Goat Cyber

Want a partner who runs this playbook for a living? Blue Goat Cyber executes every move in this playbook end-to-end, threat modeling, SBOMs, penetration testing, SPDF, submission documentation, and post-market monitoring.  [Book a 30-min strategy session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

The Crosswalk

An independent reference for global medical device cybersecurity standards. A field guide for MedTech innovators and RA/QA teams charting an international path.

Resource

-   [Comparison matrix](/compare)
-   [Global playbook](/playbook)
-   [Glossary](/glossary)
-   [FAQ](/faq)

Sponsored by

[Blue Goat Cyber ↗](https://bluegoatcyber.com)

Editorially independent. Sponsorship keeps it free.

© 2026 The Crosswalk. Not legal advice.

Validate every requirement against current regulator publications.